Earningsreport

Q3/2024 6/30/2024 EPS -0.060 ZacksConsensus -0.050 ActVsEst (0.010) - Miss

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com